Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed lower by over 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週二收盤下跌400多點。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。
Aclaris Therapeutics
Aclaris Therape
- The Trade: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Director Andrew Kenneth William Powell acquired a total of 14,500 shares an average price of $1.24. To acquire these shares, it cost around $17,955.
- What's Happening: Aclaris Therapeutics reported its fourth-quarter earnings results on Feb. 27, 2024.
- What Aclaris Therapeutics Does: Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases.
- 交易：Aclaris Therapeutics, Inc.（納斯達克股票代碼：ACRS）董事安德魯·肯尼思·威廉·鮑威爾 共收購了 14,500 股股票 平均價格爲1.24美元。收購這些股票的成本約爲17,955美元。
- 發生了什麼：Aclaris Therapeutics於2024年2月27日公佈了其第四季度業績。
- Aclaris Therapeutics的所作所爲：Aclaris Therapeutics Inc是一家臨床階段的生物製藥公司，在美國運營。它專注於開發免疫炎症性疾病的新型候選藥物。
Lumen Technologies
流明科技
- The Trade: Lumen Technologies, Inc. (NASDAQ:LUMN) Director Laurie Siegel acquired a total of 30,000 shares at at an average price of $1.60. To acquire these shares, it cost around $47,997.
- What's Happening: On March 1, Lumen Technologies named Ryan Asdourian as its new Executive Vice President and Chief Marketing Officer.
- What Lumen Technologies Does: With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises.
- 交易：Lumen Technologies, Inc.（納斯達克股票代碼：LUMN）董事勞裏·西格爾 共收購了 30,000 股股票 平均價格爲1.60美元。收購這些股票的成本約爲47,997美元。
- 發生了什麼：3月1日，Lumen Technologies任命瑞安·阿斯杜裏安爲新任執行副總裁兼首席營銷官。
- Lumen Technologies的業務：Lumen Technologies擁有45萬英里的光纖，是美國最大的電信運營商之一，爲全球企業提供服務。
Check This Out: Campbell Soup, Box And 3 Stocks To Watch Heading Into Wednesday
看看這個： Campbell Soup、Box 和 3 只股票在週三值得關注
Personalis
個人主義
- The Trade: Personalis, Inc. (NASDAQ:PSNL) Director Woodrow A Myers Jr acquired a total of 10,000 shares at an average price of $1.67. The insider spent around $16,700 to buy those shares.
- What's Happening: On Feb. 28, Personalis posted downbeat quarterly results.
- What Personalis Does: Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.
- 貿易：Personalis, Inc.（納斯達克股票代碼：PSNL）董事小伍德羅·邁爾斯 共收購了 10,000 股股票 平均價格爲1.67美元。知情人士花費了約16,700美元購買了這些股票。
- 發生了什麼：2月28日，Personalis公佈了悲觀的季度業績。
- Personalis做什麼：Personalis Inc是基因組測序和分析解決方案的提供商，以支持個性化癌症疫苗和其他下一代癌症免疫療法的開發。
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
譯文內容由第三人軟體翻譯。